Corpus Intelligence IC Memo — HCA FLORIDA WESTSIDE HOSPITAL 2026-04-26 08:03 UTC
IC Memo — HCA FLORIDA WESTSIDE HOSPITAL
Investment Committee Memorandum | FL | 250 beds | Grade C | EBITDA uplift $23.4M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

HCA FLORIDA WESTSIDE HOSPITAL

CCN 100228 | BROWARD, FL | 250 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

HCA FLORIDA WESTSIDE HOSPITAL is a 250-bed suburban community hospital in BROWARD, FL with $317.3M in net patient revenue and a 34.8% operating margin. The hospital serves a payer mix of 22.0% Medicare, 3.1% Medicaid, and 74.9% commercial.

Thesis: Platform Growth. Our ML models identify $23.4M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 34.8% to 42.1% (+736bps).

Net Revenue HCRIS$317.3M
Current EBITDA COMPUTED$110.4M
Operating Margin COMPUTED34.8%
Occupancy HCRIS69.3%
Revenue / Bed COMPUTED$1.3M
Net-to-Gross HCRIS10.3%
Distress Probability ML41.5%

2. Market Context & Competitive Position

261
FL Hospitals
3.2%
State Median Margin
112
Comparable Hospitals

FL has 261 Medicare-certified hospitals with a median operating margin of 3.2%. The target's margin of 34.8% places it above the state median. Among 112 size-comparable peers (125-500 beds), the median margin is 2.8%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (125-500), prioritizing same-state peers. 112 hospitals in the comp set.

HospitalStateBedsRevenueMargin
HCA FLORIDA WESTSIDE HOSPITAL (Target)FL250$317.3M34.8%
MOFFITT CANCER CENTERFL218$1.91B16.0%
MAYO CLINIC FLORIDAFL304$1.09B21.6%
MOUNT SINAI MEDICAL CENTER OF FL481$904.2M12.2%
TALLAHASSEE MEMORIAL HOSPITALFL483$871.6M-4.8%
SHANDS JACKSONVILLE MEDICAL CEFL481$861.4M-7.1%
NICKLAUS CHILDRENS HOSPITALFL259$769.3M5.5%
MEMORIAL HOSPITAL WESTFL486$741.4M5.2%
SOUTH MIAMI HOSPITALFL375$688.4M11.6%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $23.4M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$6.7M+210bp18mo
Cost to Collect4.5%2.5%$6.3M+200bp12mo
Denial Rate Reduction12.0%6.5%$6.3M+198bp12mo
A/R Days Reduction5200.0%3800.0%$3.9M+122bp9mo
Clean Claim Rate88.0%96.0%$203K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$6.7M
Cost to Collect
$6.3M
Denial Rate Reduction
$6.3M
A/R Days Reduction
$3.9M
Clean Claim Rate
$203K
Total EBITDA Uplift$23.4M
Current EBITDA$110.4M
+ RCM Uplift+$23.4M
Pro Forma EBITDA$133.7M
Current Margin34.8%
Pro Forma Margin42.1%
WC Released (1x)$12.2M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$169.8M$961.5M5.66x41.4%
Base (11x exit)10.0x11.0x$169.8M$1.11B6.55x45.6%
Bull Case9.0x11.0x$152.8M$1.24B8.15x52.1%
Bull (12x exit)9.0x12.0x$152.8M$1.40B9.18x55.8%
Bear Case11.0x10.0x$186.8M$789.6M4.23x33.4%
Bear (11x exit)11.0x11.0x$186.8M$929.2M4.98x37.8%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
LowLow net-to-gross ratioLarge contractual allowances suggest pricing discipline issues. Mitigant: payer renegotiation is an additional upside lever

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 112 hospitals with 125-500 beds
  • Same-state prioritization (n=113)
  • Comp margins: P25=-5.3% / P50=2.8% / P75=16.6%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.